CARA Stock Price, Forecast & News (Cara Therapeutics) On average, they anticipate Cara Therapeutics' stock price to reach $33.80 in the next twelve months. This suggests a possible upside of 163.7% from the stock's current price. View analysts' price targets for Cara Therapeutics . Why Cara Therapeutics Stock Is Plunging Today | The Motley ... Why Cara Therapeutics Stock Is Plunging Today Cara Therapeutics CEO Derek Chalmers said that the company expects to begin a pivotal phase 3 clinical study for Oral Korsuva in treating CKD Cara Therapeutics, Inc. - CARA - Stock Price Today - Zacks View Cara Therapeutics, Inc. CARA investment & stock information. Get the latest Cara Therapeutics, Inc. CARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Cara Therapeutics, Inc. Common Stock (CARA) Real-Time ...
Stock quote for Cara Therapeutics, Inc. Common Stock Common Stock (CARA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
Cara Therapeutics, Inc. (CARA) Stock Historical Prices ... 102 rows · Discover historical prices for CARA stock on Yahoo Finance. View daily, weekly or monthly … CARA Stock Quote - Cara Therapeutics, Inc. Common Stock ... Stock quote for Cara Therapeutics, Inc. Common Stock Common Stock (CARA) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. CARA Stock Quote - CARA Therapeutics, Inc. Stock Price Today CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics. Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.
Cara Therapeutics Inc CARA - Quotes, Financials, News ...
Learn about CARA with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on CARA. Stock Style. Large-Cap Value CARA Cara Therapeutics, Inc. daily Stock Chart. CARA [NASD] Aug-12-19, Reiterated, H.C. Wainwright, Buy, $31 → $30. May-29-19, Reiterated, Laidlaw, Buy CARA:Cara Therapeutics Inc - Stock Price Quote and Dividend Data. LATEST CLOSE STOCK PRICE. $12.82. EXCHANGE. NASDAQ Jun 1, 2018 When Cara Therapeutics Inc (NASDAQ:CARA) announced a new Why would traders push the CARA stock price below a predictable price
The score shows how a stock's price performance over the trailing 52 weeks holds up against all the other stocks in our database. Over 100 years of market history
Executive Summary. Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. Cara Therapeutics Stock Quote. CARA - Stock Price, News ... Cara Therapeutics (CARA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. CARA - Stock quote for CARA THERAPEUTICS, INC. - MSN Money
In depth view into CARA (Cara Therapeutics) stock including the latest price, news, dividend history, earnings information and financials.
CARA - Stock quote for CARA THERAPEUTICS, INC. - MSN Money
About Cara Therapeutics Inc CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics.